Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by M. M. Yore
Prevention and Treatment of Experimental Estrogen Receptor-Negative Mammary Carcinogenesis by the Synthetic Triterpenoid CDDO-Methyl Ester and the Rexinoid LG100268
Clinical Cancer Research
Cancer Research
Oncology
Related publications
The Combination of Tamoxifen and the Rexinoid LG100268 Prevents ER-Positive and ER-Negative Mammary Tumors in P53-Null Mammary Gland Mice
Cancer Prevention Research
Medicine
Cancer Research
Oncology
The SERM, Arzoxifene, and the Rexinoid, LG100268, Cooperate to Prevent Estrogen Receptor-Positive and -Negative Breast Cancer as Well as Colon Cancer.
CDDO-Me Alters the Tumor Microenvironment in Estrogen Receptor Negative Breast Cancer
Scientific Reports
Multidisciplinary
Increased Estrogen Receptor Cx Expression During Mammary Carcinogenesis
Clinical Cancer Research
Cancer Research
Oncology
The Synthetic Triterpenoid, CDDO-Me, Modulates the Proinflammatory Response toIn VivoLipopolysaccharide Challenge
Journal of Interferon and Cytokine Research
Medicine
Virology
Immunology
Cell Biology
Prevention of Prostate Cancer With Oleanane Synthetic Triterpenoid CDDO-Me in the TRAMP Mouse Model of Prostate Cancer
Cancers
Cancer Research
Oncology
Neuroprotective Effects of the Triterpenoid, CDDO Methyl Amide, a Potent Inducer of Nrf2-Mediated Transcription
PLoS ONE
Multidisciplinary
N-Methyl-N-Nitrosourea-Induced Mammary Carcinogenesis Is Promoted by Short-Term Treatment With Estrogen and Progesterone Mimicking Pregnancy in Aged Female Lewis Rats
Oncology Reports
Medicine
Cancer Research
Oncology
Neonatal Experiences Differentially Influence Mammary Gland Morphology, Estrogen Receptor Protein Levels, and Carcinogenesis in BALB/c Mice
Cancer Prevention Research
Medicine
Cancer Research
Oncology
